Codiak BioSciences, Inc. Net Change in Cash
Codiak BioSciences, Inc. reported Net Change in Cash of -$25.18 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2022-11-03
- Codiak BioSciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$20.44M, a 149.43% decline year-over-year.
- Codiak BioSciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $41.36M, a 10.21% increase year-over-year.
- Codiak BioSciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was $37.53M.
- Codiak BioSciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$11.98M, a 115.31% decline from fiscal 2020.
- Codiak BioSciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $78.23M.
- Codiak BioSciences, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was -$3.61M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$25.18M 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | -$35.15M 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | -$20.44M 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | -$11.98M 10-K · filed 2022-03-10 | |||
| 2021-09-30 | $9.67M 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | $24.77M 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | $41.36M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $78.23M 10-K · filed 2022-03-10 | |||
| 2020-09-30 | $37.66M 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | $40.63M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | $37.53M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | -$3.61M 10-K · filed 2021-03-17 | |||
| 2019-09-30 | $18.14M 10-Q · filed 2020-11-19 |